Influence of artificial intelligence in modern pharmaceutical formulation and drug development

被引:14
作者
Ali, Kazi Asraf [1 ]
Mohin, S. K. [1 ]
Mondal, Puja [1 ]
Goswami, Susmita [1 ]
Choudhuri, Sabyasachi [1 ]
Ghosh, Soumya [1 ]
机构
[1] Maulana Abul Kalam Azad Univ Technol, Dept Pharmaceut Technol, Haringhata 741249, W Bengal, India
关键词
Artificial intelligence; Machine learning; Nano medicine; Nano robots; Pharmaceutical formulation; Drug development; DELIVERY SYSTEMS SEDDS; NEURAL-NETWORKS; PARTICLE-SIZE; PREDICTIVE CONTROL; SOLID DISPERSIONS; GENETIC ALGORITHM; RESPONSE-SURFACE; PHASE-BEHAVIOR; ORAL DELIVERY; RELEASE;
D O I
10.1186/s43094-024-00625-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Artificial intelligence (AI) revolutionized the formulation and development of modern pharmaceuticals. With the help of AI, researchers can now optimize drug design, develop formulations, and streamline clinical trials in a much accurate and efficient way. Drug development might be greatly expedited and time-consuming procedure; however, with the help of AI this are significantly reduced.Main body of abstract The main advantages of AI in pharmaceutical formulation are its capacity to analyse vast amounts of data and spot patterns and connections that human researchers would miss. Various tools and technologies, such as ANN, fuzzy logic, neuro-fuzzy logic, and genetic algorithm are used for analysing the date, of which ANN is popular and mostly used. AI enables the discovery of novel pharmacological targets and the creation of more potent medications. AI may also be used to improve medication formulations by forecasting the solubility, stability, and bioavailability of drug candidates, increasing the likelihood that clinical trials will be successful. AI is also applied in designing clinical trials, reducing the time and cost of the process by identifying patient populations that are most likely to benefit from the treatment. Additionally, AI can monitor patients during clinical trials, detecting real-time adverse effects and adjusting dosages to improve patient outcomes.Main body of abstract The main advantages of AI in pharmaceutical formulation are its capacity to analyse vast amounts of data and spot patterns and connections that human researchers would miss. Various tools and technologies, such as ANN, fuzzy logic, neuro-fuzzy logic, and genetic algorithm are used for analysing the date, of which ANN is popular and mostly used. AI enables the discovery of novel pharmacological targets and the creation of more potent medications. AI may also be used to improve medication formulations by forecasting the solubility, stability, and bioavailability of drug candidates, increasing the likelihood that clinical trials will be successful. AI is also applied in designing clinical trials, reducing the time and cost of the process by identifying patient populations that are most likely to benefit from the treatment. Additionally, AI can monitor patients during clinical trials, detecting real-time adverse effects and adjusting dosages to improve patient outcomes.Conclusion AI is a potent pharmaceutical formulation and development tool, allowing researchers to analyse vast amounts of data, optimize drug formulations, and streamline clinical trials. As technology develops, experts anticipate that AI will increasingly show a crucial part in drug development, enabling faster, more efficient, and more effective treatments for various diseases.
引用
收藏
页数:15
相关论文
共 112 条
[61]   Analysis of pellet properties with use of artificial neural networks [J].
Mendyk, Aleksander ;
Kleinebudde, Peter ;
Thommes, Markus ;
Yoo, Angelina ;
Szlek, Jakub ;
Jachowicz, Renata .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 41 (3-4) :421-429
[62]   De Novo Design of Bioactive Small Molecules by Artificial Intelligence [J].
Merk, Daniel ;
Friedrich, Lukas ;
Grisoni, Francesca ;
Schneider, Gisbert .
MOLECULAR INFORMATICS, 2018, 37 (1-2)
[63]   Computer-Assisted Drug Formulation Design: Novel Approach in Drug Delivery [J].
Metwally, Abdelkader A. ;
Hathout, Rania M. .
MOLECULAR PHARMACEUTICS, 2015, 12 (08) :2800-2810
[64]  
Mishra SS, 2018, FOOD MICROBIOL FOOD, P121, DOI 10.1007/978-3-319-74820-7_7
[65]  
Mohs Richard C, 2017, Alzheimers Dement (N Y), V3, P651, DOI 10.1016/j.trci.2017.10.005
[66]   Use of Model Predictive Control and Artificial Neural Networks to Optimize the Ultrasonic Release of a Model Drug From Liposomes [J].
Moussa, Hesham G. ;
Husseini, Ghaleb A. ;
Abel-Jabbar, Nabil ;
Ahmad, Salma E. .
IEEE TRANSACTIONS ON NANOBIOSCIENCE, 2017, 16 (03) :149-156
[67]   An adaptive drug delivery design using neural networks for effective treatment of infectious diseases: A simulation study [J].
Padhi, Radhakant ;
Bhardhwaj, Jayender R. .
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2009, 94 (03) :207-222
[68]   Comparative Study for Optimization of Pharmaceutical Self-Emulsifying Pre-concentrate by Design of Experiment and Artificial Neural Network [J].
Parikh, Kinjal J. ;
Sawant, Krutika K. .
AAPS PHARMSCITECH, 2018, 19 (07) :3311-3321
[69]  
Patel T.B., 2015, Bulletin of Pharmaceutical Research, V5, P20
[70]   Artificial intelligence in drug discovery and development [J].
Paul, Debleena ;
Sanap, Gaurav ;
Shenoy, Snehal ;
Kalyane, Dnyaneshwar ;
Kalia, Kiran ;
Tekade, Rakesh K. .
DRUG DISCOVERY TODAY, 2020, 26 (01) :80-93